AMDL Product OKd
<i> Dow Jones</i>
AMDL Inc., a Tustin developer of diagnostic tests for diseases, said Monday that the Food and Drug Administration has given the company clearance to market a test to detect antibodies to a bacteria known to cause ulcers and, if untreated, stomach cancer.
AMDL said its diagnostic test is a direct enzyme immunoassay that determines if there are antibodies to the bacteria, Helicobacter pylori, in a patient’s blood.
AMDL said it is discussing marketing programs for the test with distributors.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
